• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Camilla Raiborg, Kristi Gronvold Bache, David J. Gillooly, Inger Helene Madshus, Espen Stang, Harald Stenmark
  • Biology, Medicine
  • Nature Cell Biology
  • 2002 (First Publication: 1 May 2002)
  • After endocytosis, some membrane proteins recycle from early endosomes to the plasma membrane whereas others are transported to late endosomes and lysosomes for degradation. Conjugation with theExpand
  • Karianne Eide Longva, Frøydis D Blystad, Espen Stang, Astrid M. Larsen, Lene E. Johannessen, Inger Helene Madshus
  • Biology, Medicine
  • The Journal of cell biology
  • 2002 (First Publication: 4 March 2002)
  • EGF, but not TGFα, efficiently induces degradation of the EGF receptor (EGFR). We show that EGFR was initially polyubiquitinated to the same extent upon incubation with EGF and TGFα, whereas theExpand
  • Tove Ringerike, Frøydis D Blystad, Finn Olav Levy, Inger Helene Madshus, Espen Stang
  • Biology, Medicine
  • Journal of cell science
  • 2002 (First Publication: 15 March 2002)
  • We have investigated the localization and function of the epidermal growth factor receptor (EGFR) in normal cells, in cholesterol-depleted cells and in cholesterol enriched cells. UsingExpand
  • Lene Melsaether Grøvdal, Espen Stang, Alexander Sorkin, Inger Helene Madshus
  • Biology, Medicine
  • Experimental cell research
  • 2004 (First Publication: 1 November 2004)
  • Mutation of the binding site for Cbl (Tyr1045) in the EGF receptor (EGFR) results in impaired ubiquitination but does not affect EGFR internalization. However, the Y1045F mutation resulted inExpand
  • Karianne Eide Longva, Nina Marie Pedersen, Camilla Haslekås, Espen Stang, Inger Helene Madshus
  • Medicine, Biology
  • International journal of cancer
  • 2005 (First Publication: 1 September 2005)
  • The anti-proliferative effect of the ErbB2 specific antibody Herceptin in cells overexpressing ErbB2 has previously been explained by endocytic downregulation of ErbB2. However, in the following, weExpand